Clinical Trial Update: Latanoprost Plus NB-UVB Versus Each Alone in Non-segmental Vitiligo: Clinical and Laboratory Evaluation [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating latanoprost plus NB-UVB versus each alone for non-segmental vitiligo, with clinical and laboratory evaluation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-segmental Vitiligo

Drugs mentioned

• Latanoprost (Latanoprost)
• NB-UVB (narrowband ultraviolet-B phototherapy)

Snippet

Sponsor: Shaimaa Fawzy Abdel-rady Abdel-latif | Conditions: Non-segmental Vitiligo | Phase 4 | Status: UNKNOWN